Recent numerous studies used drug-docking for the COVID-19 viral spike protein to screen out quercetin as a disturbing binding partner, impeding coronavirus S-protein:ACE2 interface–ligand binding complex [50,51]. The gene discussed is PROS1; the disease is COVID-19.